Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04431960 · ClinicalTrials.gov registry record · Phase 1
Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk
A Phase 1 study, sponsored by University of Connecticut.
- Completed
- Registry status
- Phase 1
- Development phase
- 51
- Enrollment target
NCT04431960 is a Phase 1 study that has completed, run by University of Connecticut. The registered enrollment target is 51 participants.
The verdict
NCT04431960, a Phase 1 study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 51 participants
- Enrollment target
Study Summary
Aim to evaluate the effects of blackcurrant supplementation on changes in gut microbiome, bone mass, and CVD risk factors in adult women.
Interventions
- DRUG blackcurrant (BC) extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2022-10-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04431960
The ClinicalTrials.gov registry entry for NCT04431960 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blackcurrant (BC) extract is the first listed.
NCT04431960 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04431960 about?
NCT04431960 is a clinical study titled "Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk". Aim to evaluate the effects of blackcurrant supplementation on changes in gut microbiome, bone mass, and CVD risk factors in adult women.
What is the current status of trial NCT04431960?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 51 participants. The study started on 2021-07-20. Estimated completion is 2022-10-03.
What interventions are being tested in trial NCT04431960?
The interventions under investigation include: blackcurrant (BC) extract (DRUG).
Who is sponsoring clinical trial NCT04431960?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.